Exploring the Role of Herbal Remedies and Alternative Therapies in Managing Vitiligo: A Comprehensive Review
DOI:
https://doi.org/10.64261/rwjmr889Keywords:
Vitiligo, Melanocytes, Herbal remedies, Pigmentation, Skin conditionAbstract
Vitiligo is a persistent skin disorder characterized by the loss of pigmentation due to the destruction of melanocytes, which are responsible for producing skin color. Although the exact cause is not fully understood, it is believed to result from a combination of genetic predisposition, autoimmune responses, and environmental factors like stress or trauma. The condition leads to the formation of depigmented patches on the skin, hair, and mucous membranes. While not life-threatening, vitiligo often causes considerable psychological distress, including feelings of embarrassment, shame, and social stigma, which can significantly affect an individual’s emotional health and quality of life. Existing treatment options, such as corticosteroids, phototherapy, and surgical procedures, offer varying levels of success, but no definitive cure has been found. This has sparked increased interest in alternative treatments, particularly herbal remedies. Herbal substances like Ginkgo biloba, Curcumin, and Green Tea are being studied for their potential to reduce oxidative stress, regulate the immune system, and encourage melanocyte regeneration, offering promising non-pharmaceutical solutions for managing vitiligo. This paper offers a thorough overview of vitiligo, including its pathophysiology, classification, and epidemiology. It also examines current treatment methods, with a focus on the potential advantages of herbal remedies. Furthermore, the paper discusses ongoing research into molecular therapies aimed at improving melanocyte function and restoring pigmentation. Given the persistent nature of vitiligo and its significant psychological impact, continued exploration of both conventional and alternative treatments is vital for enhancing patient care. As research advances, new treatment approaches may provide more effective solutions for managing vitiligo and reducing its emotional and social effects. The emerging role of herbal remedies is also highlighted, positioning them as promising alternatives or supplements to conventional treatments.
References
[1] I. Khan, M. K. A. Khan, and F. M. Almarshad, “Exploring Therapeutic Approaches for Vitiligo: An Inclusive Review from Translational Modalities to Alternative Therapies,” Curr. Dermatol. Rep., vol. 13, no. 2, pp. 67–84, Mar. 2024, doi: 10.1007/s13671-024-00425-z.
[2] H. org/10. 1007/s0040.-025-04162-6eena Briget, “Beyond skin deep: exploring the complex molecular mechanisms and holistic management strategies of vitiligo,” Arch. Dermatol. Res., vol. 317, no. 1, p. 685, Apr. 2025, doi: 10.1007/s00403-025-04162-6.
[3] S. Hazari and J. A. D. P. P. Jayakody, “A comprehensive review of Vitiligo: Integrating modern medical insights with Ayurvedic concepts,” Univ. Colombo Rev., vol. 6, no. 1, pp. 68–83, Jul. 2025, doi: 10.4038/ucr.v6i1.242.
[4] A. Qawasmeh et al., “Insights into the role of Nrf2 in vitiligo pathogenesis: a target for herbal medicine,” Front. Nat. Prod., vol. 4, Jul. 2025, doi: 10.3389/fntpr.2025.1593684.
[5] A. Shakhbazova, H. Wu, C. J. Chambers, and R. K. Sivamani, “A Systematic Review of Nutrition, Supplement, and Herbal-Based Adjunctive Therapies for Vitiligo,” J. Altern. Complement. Med., vol. 27, no. 4, pp. 294–311, Apr. 2021, doi: 10.1089/acm.2020.0292.
[6] E. Castillo, M. E. González-Rosende, and I. Martínez-Solís, “The Use of Herbal Medicine in the Treatment of Vitiligo: An Updated Review,” Planta Med., vol. 89, no. 05, pp. 468–483, Apr. 2023, doi: 10.1055/a-1855-1839.
[7] M. J. Diaz, J. T. Tran, D. Rose, A. Wei, D. Lakshmipathy, and S. R. Lipner, “Dietary Interventions, Supplements, and Plant-Derived Compounds for Adjunct Vitiligo Management: A Review of the Literature,” Nutrients, vol. 17, no. 2, p. 357, Jan. 2025, doi: 10.3390/nu17020357.
[8] N. A. Shah, R. A. Mir, and S. Saltanat, “‘Understanding and treating baras (vitiligo) in unani medicine: historical perspectives, pathophysiology, and therapeutic approaches,’” J. Complement. Integr. Med., vol. 22, no. 3, pp. 390–401, Sep. 2025, doi: 10.1515/jcim-2024-0240.
[9] S. Poondru, L. J. Yang, and R. V. Kundu, “Use of complementary and alternative medicine in vitiligo: a cross-sectional survey,” Arch. Dermatol. Res., vol. 316, no. 5, p. 126, Apr. 2024, doi: 10.1007/s00403-024-02872-x.
[10] I. Binti Ismail, Y. Jabeen Bhat, and M. Shurjeel ul Islam, “Treatment advances in Vitiligo: An Updated Review,” Dermatol. Pract. Concept., vol. 15, no. 1, p. 4600, Jan. 2025, doi: 10.5826/dpc.1501a4600.
[11] S. K. Jha, V. Charde, V. Kumar, and C. V. Narasimhaji, “Vitiligo Treatment with Natural Bioactive: A Narrative Review,” Nat. Prod. J., vol. 16, no. 3, Mar. 2026, doi: 10.2174/0122103155337960241205070806.
[12] M. Bhange, S. Kothawade, D. Telange, and V. Padwal, “Emerging therapies and innovations in vitiligo management: a comprehensive review,” J. Immunoass. Immunochem., vol. 46, no. 1, pp. 1–28, Jan. 2025, doi: 10.1080/15321819.2024.2412528.
[13] Y. Jian, X. Wang, Y. Li, D. Fu, Y. Gong, and H. Shi, “Efficacy and safety of compound glycyrrhizin in combination with conventional therapy in treatment of vitiligo: A systematic review and meta-analysis of randomized controlled trials,” Medicine (Baltimore)., vol. 102, no. 43, p. e35533, Oct. 2023, doi: 10.1097/MD.0000000000035533.
[14] R. M. D. S. Rathnayake and D. Dahanayake, “Impact of herbal treatments for Vitiligo disease,” Univ. Colombo Rev., vol. 5, no. 1, pp. 145–168, Jun. 2024, doi: 10.4038/ucr.v5i1.85.
[15] Z. Hadi et al., “Exploring the impact of diet and nutrition on vitiligo: A systematic review of dietary factors and nutritional interventions,” J. Cosmet. Dermatol., vol. 23, no. 7, pp. 2320–2327, Jul. 2024, doi: 10.1111/jocd.16277.
[16] Y. Wang, P. Bu, Y. Deng, W. Zhao, and G. Pan, “Research progress on traditional Chinese medicine compounds in autoimmune-related skin diseases,” Front. Immunol., vol. 16, Oct. 2025, doi: 10.3389/fimmu.2025.1629288.
[17] I. Hussain, “The Safety of Medicinal Plants Used in the Treatment of Vitiligo and Hypermelanosis: A Systematic Review of Use and Reports of Harm,” Clin. Cosmet. Investig. Dermatol., vol. Volume 14, pp. 261–284, Mar. 2021, doi: 10.2147/CCID.S298342.
[18] X. Liang et al., “Healthy lifestyle choices: new insights into vitiligo management,” Front. Immunol., vol. 15, Nov. 2024, doi: 10.3389/fimmu.2024.1440705.
[19] A. Białczyk, A. Wełniak, B. Kamińska, and R. Czajkowski, “Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review,” Mol. Diagn. Ther., vol. 27, no. 6, pp. 723–739, Nov. 2023, doi: 10.1007/s40291-023-00672-z.
[20] A. Bishnoi and D. Parsad, “Phototherapy for vitiligo: A narrative review on the clinical and molecular aspects, and recent literature,” Photodermatol. Photoimmunol. Photomed., vol. 40, no. 3, May 2024, doi: 10.1111/phpp.12968.
[21] D. Alshiyab et al., “The Microneedle Revolution: Transforming Vitiligo Treatment Landscapes—A Comprehensive Review of the Literature,” J. Cutan. Med. Surg., vol. 29, no. 1, pp. 56–62, Jan. 2025, doi: 10.1177/12034754241290817.
[22] Y. Pang et al., “Plant-Derived Compounds as Promising Therapeutics for Vitiligo,” Front. Pharmacol., vol. 12, Nov. 2021, doi: 10.3389/fphar.2021.685116.
[23] B. Zhu, C. Liu, L. Zhang, J. Wang, M. Chen, and Y. Wei, “Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis,” J. Cosmet. Dermatol., vol. 22, no. 3, pp. 1083–1098, Mar. 2023, doi: 10.1111/jocd.15534.
[24] J. Wang et al., “Anti-vitiligo Mechanisms of Traditional Chinese Medicine Compound Baqia Danshen Liniment: Network Pharmacology, Molecular Docking, and Animal Model Insights,” Pharmacogn. Mag., vol. 21, no. 4, pp. 1537–1548, Dec. 2025, doi: 10.1177/09731296251321906.
[25] N. Sallehuddin, N. I. M. Fadilah, M. B. Fauzi, and M. Maarof, “A Scoping Review of Pathogenesis, Current Treatments, and Novel Approaches for Vitiligo,” J. Cosmet. Dermatol., vol. 24, no. 10, Oct. 2025, doi: 10.1111/jocd.70444.
[26] T. Rama Rao, H. Sharmeen, A. Tabassum, and S. J. Jasmine, “Understanding Vitiligo: Causes, Diagnosis, Promising Advances in Treatment and Management and the Impact on Mental Health,” J. Drug Deliv. Ther., vol. 14, no. 4, pp. 130–137, Apr. 2024, doi: 10.22270/jddt.v14i4.6503.
[27] G. N. Pathak, I. J. Tan, G. Bai, J. Dhillon, and B. K. Rao, “Vitiligo: From Mechanisms of Disease to Treatable Pathways,” Ski. Heal. Dis., vol. 4, no. 6, Dec. 2024, doi: 10.1002/ski2.460.
[28] F. Guarneri, L. Bertino, G. Pioggia, M. Casciaro, and S. Gangemi, “Therapies with Antioxidant Potential in Psoriasis, Vitiligo, and Lichen Planus,” Antioxidants, vol. 10, no. 7, p. 1087, Jul. 2021, doi: 10.3390/antiox10071087.
[29] J. Liu, S. Matangi, Y. Malempati, A. Nasir, and D. Rosmarin, “Prevalence and Association of Autoimmune Comorbidities Among Adults with Vitiligo: A Systematic Literature Review and Meta-analysis of USA-Based Studies,” Dermatol. Ther. (Heidelb)., vol. 15, no. 11, pp. 3109–3124, Nov. 2025, doi: 10.1007/s13555-025-01506-y.
[30] Y. Wang, S. Li, and C. Li, “Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo,” Clin. Rev. Allergy Immunol., vol. 61, no. 3, pp. 299–323, Dec. 2021, doi: 10.1007/s12016-021-08868-z.
[31] Z. Xu, Y. Xie, J. Song, J. Huang, and W. Shi, “Mechanism of Action of a Chinese Herbal Compound Containing Quercetin, Luteolin, and Kaempferol in the Treatment of Vitiligo Based on Network Pharmacology and Experimental Verification,” Evidence-Based Complement. Altern. Med., vol. 2022, pp. 1–14, Dec. 2022, doi: 10.1155/2022/7197533.
[32] X. Wang, W. Wu, J. Chen, C. Li, and S. Li, “Management of the refractory vitiligo patient: current therapeutic strategies and future options,” Front. Immunol., vol. 14, Jan. 2024, doi: 10.3389/fimmu.2023.1294919.
[33] L. Chen et al., “Exploration of the mechanism of Qinglongyi-Buguzhi drug pair in treating vitiligo based on network pharmacology, molecular docking and experimental verification,” J. Ethnopharmacol., vol. 334, p. 118595, Nov. 2024, doi: 10.1016/j.jep.2024.118595.
[34] A. Khoshrou, A. M. Arasteh Nodeh, S. Karav, and A. Sahebkar, “The Role of Nutraceuticals in Autoimmune Skin Diseases,” Clin. Drug Investig., vol. 46, no. 1, pp. 1–4, Jan. 2026, doi: 10.1007/s40261-025-01498-9.
[35] I. H. Hamzavi et al., “Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study,” Br. J. Dermatol., vol. 189, no. 5, pp. 569–577, Oct. 2023, doi: 10.1093/bjd/ljad245.
[36] H. Wang, W. Yu, T. Wang, D. Fang, Z. Wang, and Y. Wang, “Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review,” Front. Pharmacol., vol. 15, Jan. 2025, doi: 10.3389/fphar.2024.1423717.
[37] M. Parikh et al., “Technological advances in vitiligo management: perspectives on AI, mobile tools, and clinical utility,” Front. Med., vol. 12, Oct. 2025, doi: 10.3389/fmed.2025.1661554.
[38] M. Darvishi et al., “Lipid-based nanoparticles: advancing therapeutic strategies for vitiligo management,” BioImpacts, vol. 15, p. 30860, Jul. 2025, doi: 10.34172/bi.30860.
[39] Y. Yang, Y. Du, and B. Cui, “Polyphenols targeting multiple molecular targets and pathways for the treatment of vitiligo,” Front. Immunol., vol. 15, Jul. 2024, doi: 10.3389/fimmu.2024.1387329.
[40] O. Y. Elkhawaga, M. M. Ellety, S. O. Mofty, M. S. Ghanem, and A. O. Mohamed, “Review of natural compounds for potential psoriasis treatment,” Inflammopharmacology, vol. 31, no. 3, pp. 1183–1198, Jun. 2023, doi: 10.1007/s10787-023-01178-0.
[41] A. Trigunayat and P. Bhende, “Management of Shwitra (Vitiligo) through the Holistic Approach of Ayurveda,” J. Ayurveda Integr. Med. Sci., vol. 10, no. 5, pp. 221–225, Jun. 2025, doi: 10.21760/jaims.10.5.33.
[42] S. Sinha and D. Agrawal, “Medical management of vitiligo: a narrative review,” Pigment Int., vol. 12, no. 1, pp. 4–19, Jan. 2025, doi: 10.4103/pigmentinternational_12_24.
[43] H. J. Ju et al., “Surgical Interventions for Patients With Vitiligo,” JAMA Dermatology, vol. 157, no. 3, p. 307, Mar. 2021, doi: 10.1001/jamadermatol.2020.5756.
[44] K. Mythili and S. Prabakar, “Indian Herbal Formulation for Repigmentation of Vitiligo,” in 2025 Eleventh International Conference on Bio Signals, Images, and Instrumentation (ICBSII), IEEE, Mar. 2025, pp. 1–9. doi: 10.1109/ICBSII65145.2025.11013349.
[45] W.-L. Chang, W.-R. Lee, Y.-C. Kuo, and Y.-H. Huang, “Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention,” Front. Cell Dev. Biol., vol. 9, Dec. 2021, doi: 10.3389/fcell.2021.797026.
[46] X. Zhang, L. Meng, X. Ran, S. Li, and C. Wen, “Investigating the molecular mechanism of purslane‑based vitiligo treatment using network pharmacology, molecular docking and in vitro analyses,” Mol. Med. Rep., vol. 31, no. 5, pp. 1–14, Mar. 2025, doi: 10.3892/mmr.2025.13482.
[47] K. Anam, S. Ananyan, M. Rishabh, A. Dinesh, and K. Ashwin, “Zinc, copper, and selenium levels in vitiligo: a systematic review and meta-analysis,” Sci. Rep., vol. 14, no. 1, p. 23700, Oct. 2024, doi: 10.1038/s41598-024-61982-8.
[48] C. Yuan, L. Liu, D. Zeng, J. Yuan, L. Guo, and J. Zhang, “Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis,” Front. Microbiol., vol. 16, Jul. 2025, doi: 10.3389/fmicb.2025.1566267.
[49] A. Abuduaini, X. Lu, D. Zang, T. Wu, and H. A. Aisa, “Effects of a Traditional Caraway Formulation on Experimental Models of Vitiligo and Mechanisms of Melanogenesis,” Evidence-Based Complement. Altern. Med., vol. 2021, pp. 1–17, Apr. 2021, doi: 10.1155/2021/6675657.
[50] H. Hassan et al., “Harnessing Flavonoids and Nutraceuticals for Vitiligo via Targeting Oxidative Stress and Neural-Melanocyte Crosstalk,” ARC J. Dermatology, vol. 8, no. 3, pp. 10–18, 2025, doi: 10.20431/2456-0022.0803002.
[51] J. Perez-Bootello, R. Cova-Martin, J. Naharro-Rodriguez, and G. Segurado-Miravalles, “Vitiligo: Pathogenesis and New and Emerging Treatments,” Int. J. Mol. Sci., vol. 24, no. 24, p. 17306, Dec. 2023, doi: 10.3390/ijms242417306.
[52] A. Paganelli, F. Papaccio, M. Picardo, and B. Bellei, “Metabolic anomalies in vitiligo: a new frontier for drug repurposing strategies,” Front. Pharmacol., vol. 16, Apr. 2025, doi: 10.3389/fphar.2025.1546836.
[53] P. Giri, D. Desai, and M. Dwivedi, “Animal models unraveling the complexity of vitiligo pathogenesis,” Autoimmun. Rev., vol. 23, no. 4, p. 103515, Apr. 2024, doi: 10.1016/j.autrev.2024.103515.
[54] A. Bishnoi, K. B. Meghana, and D. Parsad, “Medical treatment of vitiligo: A narrative review,” Pigment Int., vol. 11, no. 3, pp. 167–180, Sep. 2024, doi: 10.4103/pigmentinternational_48_24.
[55] A. Srivastav, Y. Srivastav, A. Hameed, and M. I. Ahmad, “Prevention and cure of dermatology disorders using herbal medications: summary,” Int. J. Indig. Herbs Drugs, pp. 1–14, Feb. 2024, doi: 10.46956/ijihd.v9i1.568.
[56] Y. Ni, Y. Zhang, J. Sun, L. Zhao, B. Wu, and J. Ye, “The effect of antioxidant dietary supplements and diet-derived circulating antioxidants on vitiligo outcome: evidence from genetic association and comprehensive Mendelian randomization,” Front. Nutr., vol. 10, Jan. 2024, doi: 10.3389/fnut.2023.1280162.
[57] L. Yuan, Y. Chen, Y. Guan, X. Fu, and L. Tan, “Current Perspectives on the Potential Role of Medicinal Plants in Anti-aging, Skin-related Disorders and Stem Cell Proliferation,” Pharmacogn. Mag., May 2025, doi: 10.1177/09731296251341498.
[58] D. Bitterman et al., “The role of aryl hydrocarbon receptor agonists in the treatment of vitiligo,” Arch. Dermatol. Res., vol. 316, no. 9, p. 659, Oct. 2024, doi: 10.1007/s00403-024-03405-2.
[59] S. Tanvir, S. A. Syed, S. Hussain, R. Zia, M. Rashid, and H. Zahid, “Detection of Vitiligo Through Machine Learning and Computer‐Aided Techniques: A Systematic Review,” Biomed Res. Int., vol. 2024, no. 1, Jan. 2024, doi: 10.1155/bmri/3277546.
[60] S. Jin, S. Wan, R. Xiong, Y. Li, T. Dong, and C. Guan, “The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review,” Inflamm. Res., vol. 73, no. 8, pp. 1311–1332, Aug. 2024, doi: 10.1007/s00011-024-01900-w
Downloads
Published
Issue
Section
Categories
- Clinical and Biomedical Sciences
- Ethics, Equity, and Social Justice in Health
- Health Systems and Policy
- Indigenous Knowledge and Culture
- Mental Health and Psychological Wellbeing
- Psychosocial and Behavioral Sciences
- Public Health
- Trauma, Conflict, and Humanitarian Health
- Pharmaceutical and Therapeutic Sciences
License
Copyright (c) 2026 Pan-African Journal of Health and Psychological Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Pan-African Journal of Health and Psychological Sciences (PAJHPS) are open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Under this license:
-
Authors retain copyright and grant the journal the right of first publication.
-
The work may be shared, copied, redistributed, and adapted for any purpose, even commercially.
-
Appropriate credit must be given to the original author(s) and the journal, along with a link to the license.
-
Users must indicate if changes were made.
-
There are no restrictions on reuse, provided the original work is properly cited.
Citation:
Authors and users must cite the original work in the following manner:
Author(s). (Year). Title of the article. Pan-African Journal of Health and Psychological Sciences, Volume(Issue), page range. https://doi.org/xx.xxxx/pajhps.vXnY.xxx
Copyright Statement:
Authors grant PAJHPS a non-exclusive license to publish the work and identify itself as the original publisher. Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version (e.g., post it to a repository or publish it in a book), with acknowledgment of its initial publication in this journal.
